28478525 |
Novel Insights into the Treatment of Imatinib-Resistant Gastrointestinal Stromal Tumors
Morales-Barrera, R,
Carles, J,
Suárez, C,
García-Valverde, A,
Olivares, D,
Valverde, C,
George, S,
Serrano, C
|
Target Oncol |
2017 |
30792533 |
Complementary activity of tyrosine kinase inhibitors against secondary kit mutations in imatinib-resistant gastrointestinal stromal tumours
Heinrich, MC,
Ketzer, J,
Bauer, S,
Zhu, M,
Presnell, A,
Raut, CP,
George, S,
Mannan, AM,
Serrano, C,
Yu, C,
Sicinska, E,
Tao, DL,
Rubin, BP,
Fletcher, JA,
Mariño-Enríquez, A,
Demetri, GD,
Eilers, G,
Czaplinski, JT,
McKinley, A
|
Br. J. Cancer |
2019 |
12181401 |
Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors
Joensuu, H,
Silberman, SL,
Capdeville, R,
Peng, B,
Heinrich, MC,
Singer, S,
Roberts, PJ,
Blanke, CD,
von Mehren, M,
Eisenberg, B,
Fletcher, JA,
Demetri, GD,
Kiese, B,
Corless, C,
Silverman, SG,
Fletcher, CD,
Druker, BJ,
Janicek, M,
Dimitrijevic, S,
Tuveson, DA,
Van den Abbeele, AD
|
N. Engl. J. Med. |
2002 |